CION Cancer Clinics
CAR-T, vaccines and cell therapy for liver cancer: where things stand | CION Cancer Clinics
CAR-T cells, cancer vaccines and other cell therapies are not yet standard treatment for liver cancer. In India they are available only inside registered clinical trials, and few of those are open. This page explains what is being tested, who might be eligible, why liver tumours are harder to treat this way than blood cancers, and how to tell a real trial from an unproven offer. At CION Cancer Clinics, a multidisciplinary tumour board weighs your liver function and your scans before recommending any treatment.
On this page
- Is CAR-T or a cancer vaccine a treatment for liver cancer yet?
- What kinds of cell therapy and vaccine are being studied?
- How do I check whether a cell therapy offer is a real trial?
- What do the words in a cell therapy trial mean?
- What do families often get wrong about CAR-T and vaccines?
- Who is this not for, and what can this page not tell you?
- Common questions about CAR-T and vaccines for liver cancer
The short answer
Is CAR-T or a cancer vaccine a treatment for liver cancer yet?
Not yet. CAR-T cells, cancer vaccines and other cell therapies are being tested for liver cancer, but none is a standard treatment, and in India they are reached only through a registered clinical trial. The treatments that are standard today are surgery, transplant, ablation, TACE, radiation, and immunotherapy or targeted tablets.
Which liver cancer this page is about
This page is about hepatocellular carcinoma (HCC), the cancer that starts in the liver cells, usually in a liver already scarred by hepatitis B, hepatitis C, fatty liver or alcohol. If a scan found cancer that spread to the liver from the bowel, breast or elsewhere, the research picture is different. Start with liver cancer treatment options explained and ask which cancer you are dealing with.
Why families ask
CAR-T has changed treatment for some blood cancers, and the news reports are real. It is natural to ask whether the same thing can be done for a liver tumour. The honest answer is that solid tumours like liver cancer have proved much harder to reach, and the work is still early.
The hepatitis B vaccine is a different thing. It prevents the infection that causes most liver cancer in India. It does not treat a cancer that is already there.The approaches in trials
What kinds of cell therapy and vaccine are being studied?
They all try to teach the immune system to find and attack liver cancer cells. They do it in quite different ways.
CAR-T cells
Your own white cells are collected, changed in a laboratory so they recognise a marker on the cancer, grown in large numbers and given back through a drip. For liver cancer, researchers have mostly aimed at a marker called GPC3, which many liver cancer cells carry.
The CAR-T products approved in India are for certain blood cancers, not for liver cancer.TCR-T cells
A close cousin of CAR-T. The cells are changed to recognise small pieces of protein from inside the cancer cell, such as AFP or a protein from the hepatitis B virus. They depend on your tissue type, so not everyone can be matched.
Cancer vaccines
An injection that shows the immune system a target on the cancer. Some are made for one person from the faults found in their own tumour. Most are being tested alongside standard immunotherapy rather than on their own.
Other cell treatments
- NK cells and CIK cells, grown from blood
- Tumour-infiltrating lymphocytes, taken from the tumour itself
- Dendritic cell treatments, which train the immune system
All of these remain research for liver cancer.
Not sure whether this applies to you?
Ask an oncologistBefore you say yes
How do I check whether a cell therapy offer is a real trial?
Ask for the registration number
Every genuine trial in India is registered with the Clinical Trials Registry of India. Ask for the number, then look it up yourself. If nobody can give you one, it is not a trial.
Check what you are asked to pay
In a proper trial the experimental treatment is normally provided by the study. Being asked to pay a large sum for unproven cells, outside a trial, is a warning sign.
Read the consent form slowly
It should say what is being tested, what is already known, the risks, who to call, and that you may leave at any time. Take it home and read it with your family before signing.
Show it to your own oncologist
Bring the paperwork to the doctor who knows your scans and your liver tests. They can tell you whether the trial fits your situation, and what you would be giving up to join it.
On the paperwork
What do the words in a cell therapy trial mean?
- Antigen
- A marker on or inside a cell that the immune system can recognise. GPC3 and AFP are the antigens most studied in liver cancer.
- Leukapheresis
- Collecting white cells from your blood through a machine, a little like giving blood. It is the first step in making CAR-T or TCR-T cells.
- Lymphodepletion
- A short course of chemotherapy given before the cells, to make room for them to grow. It lowers your blood counts for a while.
- Cytokine release syndrome
- A strong immune reaction after cell therapy, with fever, low blood pressure and breathlessness. It needs close hospital monitoring.
- Phase
- How far along a trial is. Early phases test safety in small groups. Later phases compare a new treatment with the current standard.
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
Commonly believed
What do families often get wrong about CAR-T and vaccines?
Blood cancer cells carry one clear marker and float where the cells can reach them. A liver tumour is a solid mass with a hostile surrounding that switches immune cells off. That is why results in liver cancer have so far been far less striking.
It prevents infection in people who do not yet have hepatitis B. It does not treat the virus or the cancer. It is still worth giving to household members who are not yet protected.
Treatments sold outside a registered trial have not been tested in a way that shows whether they help or harm. Paying for them can use money a family needs for proven care.
Most new treatments tested in trials turn out to be no better than the standard. Standard immunotherapy and targeted tablets are themselves the result of earlier trials that worked.
Being straight with you
Who is this not for, and what can this page not tell you?
Most people with liver cancer will not be offered cell therapy, and many would not be eligible. Trials usually need a liver that still works well, often called Child-Pugh A, a person who is up and about most of the day, and a tumour with the right marker. People with advanced cirrhosis, jaundice or fluid in the abdomen are usually not suitable. People who have had a liver transplant are generally excluded, because immune treatments can trigger rejection.
It cannot tell you whether a trial is open
Trials open and close often, and very few cell therapy trials for liver cancer run in India. This page cannot say which ones are recruiting today. How to find liver cancer trials in India explains where to look.
Who can answer the real question
At CION, the tumour board looks at your scans, your liver tests and what you have already had, and tells you whether standard systemic treatment still has more to offer before a trial is worth chasing. If a suitable trial exists elsewhere, your oncologist can share your records with the trial team.
Questions we are asked
Common questions about CAR-T and vaccines for liver cancer
Is CAR-T available for liver cancer in India?
Not as a standard treatment. The CAR-T products approved in India are for certain blood cancers. For liver cancer, CAR-T is reached only through a registered clinical trial, and very few run in India. Your oncologist can check registries with you and tell you whether travelling for one makes sense.
Is there a vaccine that treats liver cancer?
No vaccine is approved to treat liver cancer. Several are being tested, most of them alongside standard immunotherapy. The hepatitis B vaccine prevents the infection behind many liver cancers, which is why vaccinating the household of a hepatitis B carrier matters, but it does not treat an existing tumour.
How is CAR-T different from the immunotherapy I was offered?
Standard immunotherapy for liver cancer is a drip of an antibody that releases the brakes on your own immune cells. CAR-T takes your cells out, rebuilds them in a laboratory and puts them back. The first is approved and widely used. The second is still being tested for liver cancer.
Should I wait for CAR-T instead of starting treatment now?
Usually not. Liver cancer can grow while you wait, and the liver can weaken, which can rule you out of both standard treatment and trials. Starting the treatment your team recommends now does not normally close the door on a trial later. Ask your oncologist directly.
Are cell therapies safe?
They can cause serious side effects, including a strong immune reaction with fever and low blood pressure, and damage to healthy tissue that carries the same marker. A damaged liver has less room to cope. This is why early trials are small and are run in centres able to manage these reactions.
A clinic is offering dendritic cell injections. Is that the same thing?
Dendritic cell treatment is a real research area, but a clinic selling it outside a registered trial is offering something unproven. Ask for the trial registration number and the published evidence. If neither exists, talk to your oncologist before paying anything or stopping standard treatment.
Can I join a trial if I have hepatitis B?
Often yes, as long as the virus is controlled with antiviral tablets. Each trial sets its own rules. Some exclude people with active infection, and some TCR-T studies specifically target cancer cells that carry hepatitis B. Keep taking your antivirals and bring your latest viral test.
Does CION give CAR-T or cell therapy for liver cancer?
No. CION gives standard immunotherapy, targeted therapy and chemotherapy, and reviews each plan at its tumour board. If a trial looks relevant, your oncologist can help you understand it and share your records with the trial team. One helpline serves every CION centre.
Meet CION's liver cancer specialists. Bring your scan reports and liver blood tests.
Our medical and surgical oncologists plan liver cancer care together, weighing the tumour and how well your liver works before choosing surgery, a liver-directed procedure or medicines.
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Sources
- American Cancer Society — What's New in Liver Cancer Research?
- American Cancer Society — Immunotherapy for Liver Cancer
- National Cancer Institute — Immunotherapy for Cancer
- Clinical Trials Registry - India — Clinical Trials Registry - India
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Keep reading
Related pages
Talk to us
Has someone offered you cell therapy or a trial?
Send us the details and your latest scans, and an oncologist will go through whether it fits your situation and what standard treatment still offers. One helpline serves every CION centre.